☰

Frederick Streeter Barrett, Ph.D. - Publications

Affiliations: 
2013- Center for Psychedelic and Consciousness Research Johns Hopkins University School of Medicine, Baltimore, MD, United States 
 2013- Behavioral Pharmacology Research Unit Johns Hopkins University School of Medicine, Baltimore, MD, United States 
 2013- Psychiatry and Behavioral Sciences Johns Hopkins University School of Medicine, Baltimore, MD, United States 
Area:
Psychedelics, Music, Affective & Cognitive Neuroscience
Website:
https://hopkinspsychedelic.org/barrett
Tree Info Grants Similar researchers PubMed Report error

48 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Sayalı C, Barrett FS. The costs and benefits of psychedelics on cognition and mood. Neuron. PMID 36681076 DOI: 10.1016/j.neuron.2022.12.031  0.738
2022 Doss MK, Barrett FS, Corlett PR. Skepticism about Recent Evidence That Psilocybin "Liberates" Depressed Minds. Acs Chemical Neuroscience. PMID 36001741 DOI: 10.1021/acschemneuro.2c00461  0.759
2022 Gaddis A, Lidstone DE, Nebel MB, Griffiths R, Mostofsky SH, Mejia A, Barrett F. PSILOCYBIN INDUCES SPATIALLY CONSTRAINED ALTERATIONS IN THALAMIC FUNCTIONAL ORGANIZATON AND CONNECTIVITY. Neuroimage. 119434. PMID 35792293 DOI: 10.1016/j.neuroimage.2022.119434  0.544
2022 McCulloch DE, Knudsen GM, Barrett FS, Doss MK, Carhart-Harris RL, Rosas FE, Deco G, Kringelbach ML, Preller KH, Ramaekers JG, Mason NL, Müller F, Fisher PM. Psychedelic resting-state neuroimaging: A review and perspective on balancing replication and novel analyses. Neuroscience and Biobehavioral Reviews. 138: 104689. PMID 35588933 DOI: 10.1016/j.neubiorev.2022.104689  0.759
2022 Gukasyan N, Davis AK, Barrett FS, Cosimano MP, Sepeda ND, Johnson MW, Griffiths RR. Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up. Journal of Psychopharmacology (Oxford, England). 36: 151-158. PMID 35166158 DOI: 10.1177/02698811211073759  0.573
2021 Doss MK, Madden MB, Gaddis A, Nebel MB, Griffiths RR, Mathur BN, Barrett FS. Models of psychedelic drug action: modulation of cortical-subcortical circuits. Brain : a Journal of Neurology. PMID 34897383 DOI: 10.1093/brain/awab406  0.748
2021 Doss MK, Považan M, Rosenberg MD, Sepeda ND, Davis AK, Finan PH, Smith GS, Pekar JJ, Barker PB, Griffiths RR, Barrett FS. Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder. Translational Psychiatry. 11: 574. PMID 34750350 DOI: 10.1038/s41398-021-01706-y  0.751
2021 Nayak SM, Gukasyan N, Barrett FS, Erowid E, Erowid F, Griffiths RR. Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports. Pharmacopsychiatry. PMID 34348413 DOI: 10.1055/a-1524-2794  0.525
2021 Yaden DB, Johnson MW, Griffiths RR, Doss M, Garcia-Romeu A, Nayak S, Gukasayan N, Mathur BN, Barrett FS. Psychedelics and Consciousness: Distinctions, Demarcations, and Opportunities. The International Journal of Neuropsychopharmacology. PMID 33987652 DOI: 10.1093/ijnp/pyab026  0.745
2021 Garcia-Romeu A, Barrett FS, Carbonaro TM, Johnson MW, Griffiths RR. Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches. Journal of Psychopharmacology (Oxford, England). 269881121991822. PMID 33611977 DOI: 10.1177/0269881121991822  0.743
2021 Davis AK, Barrett FS, So S, Gukasyan N, Swift TC, Griffiths RR. Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD. Journal of Psychopharmacology (Oxford, England). 269881120967878. PMID 33427007 DOI: 10.1177/0269881120967878  0.542
2020 Davis AK, Barrett FS, May DG, Cosimano MP, Sepeda ND, Johnson MW, Finan PH, Griffiths RR. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial. Jama Psychiatry. PMID 33146667 DOI: 10.1001/jamapsychiatry.2020.3285  0.581
2020 Doss MK, May DG, Johnson MW, Clifton JM, Hedrick SL, Prisinzano TE, Griffiths RR, Barrett FS. The Acute Effects of the Atypical Dissociative Hallucinogen Salvinorin A on Functional Connectivity in the Human Brain. Scientific Reports. 10: 16392. PMID 33009457 DOI: 10.1038/s41598-020-73216-8  0.75
2020 Davis AK, Barrett FS, Griffiths RR. Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety. Journal of Contextual Behavioral Science. 15: 39-45. PMID 32864325 DOI: 10.1016/J.Jcbs.2019.11.004  0.608
2020 Barrett FS, Krimmel SR, Griffiths R, Seminowicz DA, Mathur BN. Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention. Neuroimage. 116980. PMID 32454209 DOI: 10.1016/J.Neuroimage.2020.116980  0.591
2020 Barrett FS, Doss MK, Sepeda ND, Pekar JJ, Griffiths RR. Emotions and brain function are altered up to one month after a single high dose of psilocybin. Scientific Reports. 10: 2214. PMID 32042038 DOI: 10.1038/S41598-020-59282-Y  0.759
2019 Barrett KC, Barrett F, Jiradejvong P, Rankin SK, Landau A, Limb CJ. Classical creativity: A functional magnetic resonance imaging (fMRI) investigation of pianist and improviser Gabriela Montero. Neuroimage. 116496. PMID 31899286 DOI: 10.1016/J.Neuroimage.2019.116496  0.359
2018 Johnson MW, Hendricks PS, Barrett FS, Griffiths RR. Classic Psychedelics: An integrative review of epidemiology, mystical experience, brain network function, and therapeutics. Pharmacology & Therapeutics. PMID 30521880 DOI: 10.1016/J.Pharmthera.2018.11.010  0.678
2018 Barrett FS, Preller KH, Kaelen M. Psychedelics and music: neuroscience and therapeutic implications. International Review of Psychiatry (Abingdon, England). 1-13. PMID 30240282 DOI: 10.1080/09540261.2018.1484342  0.341
2018 Barrett FS, Carbonaro TM, Hurwitz E, Johnson MW, Griffiths RR. Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition. Psychopharmacology. PMID 30062577 DOI: 10.1007/S00213-018-4981-X  0.766
2017 Barrett FS, Preller KH, Herdener M, Janata P, Vollenweider FX. Serotonin 2A Receptor Signaling Underlies LSD-induced Alteration of the Neural Response to Dynamic Changes in Music. Cerebral Cortex (New York, N.Y. : 1991). 1-12. PMID 29028939 DOI: 10.1093/Cercor/Bhx257  0.663
2017 Griffiths RR, Johnson MW, Richards WA, Richards BD, Jesse R, MacLean KA, Barrett FS, Cosimano MP, Klinedinst MA. Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors. Journal of Psychopharmacology (Oxford, England). 269881117731279. PMID 29020861 DOI: 10.1177/0269881117731279  0.778
2017 Barrett FS, Robbins H, Smooke D, Brown JL, Griffiths RR. Qualitative and Quantitative Features of Music Reported to Support Peak Mystical Experiences during Psychedelic Therapy Sessions. Frontiers in Psychology. 8: 1238. PMID 28790944 DOI: 10.3389/Fpsyg.2017.01238  0.61
2017 Barrett FS, Johnson MW, Griffiths RR. Neuroticism is associated with challenging experiences with psilocybin mushrooms. Personality and Individual Differences. 117: 155-160. PMID 28781400 DOI: 10.1016/J.Paid.2017.06.004  0.648
2017 Barrett FS, Griffiths RR. Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates. Current Topics in Behavioral Neurosciences. PMID 28401522 DOI: 10.1007/7854_2017_474  0.648
2017 Barrett FS, Workman CI, Sair HI, Savonenko AV, Kraut MA, Sodums DJ, Joo JJ, Nassery N, Marano CM, Munro CA, Brandt J, Zhou Y, Wong DF, Smith GS. Association between serotonin denervation and resting-state functional connectivity in mild cognitive impairment. Human Brain Mapping. PMID 28379618 DOI: 10.1002/Hbm.23595  0.331
2017 Barrett FS, Griffiths RR. The factor structure of the Mystical Experience Questionnaire (MEQ): Reply to Bouso et al., 2016. Human Psychopharmacology. 32. PMID 28120488 DOI: 10.1002/Hup.2564  0.527
2017 Barrett FS, Johnson MW, Griffiths RR. Psilocybin in long-term meditators: Effects on default mode network functional connectivity and retrospective ratings of qualitative experience Drug and Alcohol Dependence. 171: e15-e16. DOI: 10.1016/J.Drugalcdep.2016.08.058  0.62
2016 Barrett FS, Bradstreet MP, Leoutsakos JS, Johnson MW, Griffiths RR. The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms. Journal of Psychopharmacology (Oxford, England). PMID 27856683 DOI: 10.1177/0269881116678781  0.667
2016 Dunn KE, Barrett FS, Yepez-Laubach C, Meyer AC, Hruska BJ, Petrush K, Berman S, Sigmon SC, Fingerhood M, Bigelow GE. Opioid Overdose Experience, Risk Behaviors, and Knowledge in Drug Users from a Rural versus an Urban Setting. Journal of Substance Abuse Treatment. 71: 1-7. PMID 27672239 DOI: 10.1016/J.Jsat.2016.08.006  0.552
2016 Dunn KE, Barrett FS, Herrmann ES, Plebani JG, Sigmon SC, Johnson MW. Behavioral risk assessment for infectious diseases (BRAID): Self-report instrument to assess injection and noninjection risk behaviors in substance users. Drug and Alcohol Dependence. 168: 69-75. PMID 27615403 DOI: 10.1016/J.Drugalcdep.2016.07.032  0.59
2016 Carbonaro TM, Bradstreet MP, Barrett FS, MacLean KA, Jesse R, Johnson MW, Griffiths RR. Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences. Journal of Psychopharmacology (Oxford, England). PMID 27578767 DOI: 10.1177/0269881116662634  0.766
2016 Barrett FS, Janata P. Neural responses to nostalgia-evoking music modeled by elements of dynamic musical structure and individual differences in affective traits. Neuropsychologia. PMID 27526666 DOI: 10.1016/J.Neuropsychologia.2016.08.012  0.682
2016 Dunn KE, Barrett FS, Yepez-Laubach C, Meyer AC, Hruska BJ, Sigmon SC, Fingerhood M, Bigelow GE. Brief Opioid Overdose Knowledge (BOOK): A Questionnaire to Assess Overdose Knowledge in Individuals Who Use Illicit or Prescribed Opioids. Journal of Addiction Medicine. PMID 27504923 DOI: 10.1097/Adm.0000000000000235  0.536
2016 Kaelen M, Roseman L, Kahan J, Santos-Ribeiro A, Orban C, Lorenz R, Barrett FS, Bolstridge M, Williams T, Williams L, Wall MB, Feilding A, Muthukumaraswamy S, Nutt DJ, Carhart-Harris R. LSD modulates music-induced imagery via changes in parahippocampal connectivity. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 27084302 DOI: 10.1016/J.Euroneuro.2016.03.018  0.347
2016 Dunn KE, Barrett FS, Yepez-Laubach C, Meyer AC, Hruska BJ, Petrush K, Berman S, Sigmon SC, Fingerhood M, Bigelow GE. Opioid overdose experience, risk behaviors, and knowledge in drug users from a rural versus an urban setting Journal of Substance Abuse Treatment. 71: 1-7. DOI: 10.1016/j.jsat.2016.08.006  0.522
2015 Barrett FS, Johnson MW, Griffiths RR. Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin. Journal of Psychopharmacology (Oxford, England). 29: 1182-90. PMID 26442957 DOI: 10.1177/0269881115609019  0.659
2015 Carbonaro TM, Barrett FS, Bradstreet MP, Johnson MW, MacLean KA, Jesse R, Griffiths RR. Survey study of challenging experiences after ingesting psilocybin mushrooms: Demographics and phenomenology Drug and Alcohol Dependence. 146: e239-e240. DOI: 10.1016/J.Drugalcdep.2014.09.118  0.754
2015 Barrett FS, Bradstreet MP, Leoutsakos JS, Johnson MW, MacLean KA, Jesse R, Griffiths RR. The challenging experience questionnaire: Characterization of acute adverse reactions to psilocybin Drug and Alcohol Dependence. 146: e218. DOI: 10.1016/J.Drugalcdep.2014.09.060  0.742
2014 Collins T, Tillmann B, Barrett FS, Delbé C, Janata P. A combined model of sensory and cognitive representations underlying tonal expectations in music: from audio signals to behavior. Psychological Review. 121: 33-65. PMID 24490788 DOI: 10.1037/A0034695  0.766
2013 Barrett FS, Robins RW, Janata P. A brief form of the Affective Neuroscience Personality Scales. Psychological Assessment. 25: 826-43. PMID 23647046 DOI: 10.1037/A0032576  0.711
2010 Barrett FS, Grimm KJ, Robins RW, Wildschut T, Sedikides C, Janata P. Music-evoked nostalgia: affect, memory, and personality. Emotion (Washington, D.C.). 10: 390-403. PMID 20515227 DOI: 10.1037/A0019006  0.728
2008 Kohler CG, Martin EA, Stolar N, Barrett FS, Verma R, Brensinger C, Bilker W, Gur RE, Gur RC. Static posed and evoked facial expressions of emotions in schizophrenia. Schizophrenia Research. 105: 49-60. PMID 18789845 DOI: 10.1016/J.Schres.2008.05.010  0.431
2008 Shen GH, Sylvia LG, Alloy LB, Barrett F, Kohner M, Iacoviello B, Mills A. Lifestyle regularity and cyclothymic symptomatology. Journal of Clinical Psychology. 64: 482-500. PMID 18322928 DOI: 10.1002/Jclp.20440  0.496
2008 Kohler CG, Loughead J, Ruparel K, Indersmitten T, Barrett FS, Gur RE, Gur RC. Brain activation during eye gaze discrimination in stable schizophrenia. Schizophrenia Research. 99: 286-93. PMID 18248794 DOI: 10.1016/J.Schres.2007.09.038  0.448
2008 Wang P, Barrett F, Martin E, Milonova M, Gur RE, Gur RC, Kohler C, Verma R. Automated video-based facial expression analysis of neuropsychiatric disorders. Journal of Neuroscience Methods. 168: 224-38. PMID 18045693 DOI: 10.1016/J.Jneumeth.2007.09.030  0.421
2007 Alvino C, Kohler C, Barrett F, Gur RE, Gur RC, Verma R. Computerized measurement of facial expression of emotions in schizophrenia. Journal of Neuroscience Methods. 163: 350-61. PMID 17442398 DOI: 10.1016/J.Jneumeth.2007.03.002  0.44
2007 Kohler CG, Barrett FS, Gur RC, Turetsky BI, Moberg PJ. Association between facial emotion recognition and odor identification in schizophrenia. The Journal of Neuropsychiatry and Clinical Neurosciences. 19: 128-31. PMID 17431057 DOI: 10.1176/Jnp.2007.19.2.128  0.328
Show low-probability matches.